Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JOHNSON & JOHNSONJNJ · Entity 2722 | Director | April 23, 2026 | April 27, 2026 |
| NUCOR CORPNUE · Entity 3010 | Director | June 01, 2026 | June 03, 2026 |
| TENET HEALTHCARE CORPTHC · Entity 2563 | Director | September 02, 2026 | September 04, 2026 |
| Tempus AI, Inc.TEM · Entity 1545 | Director | August 28, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JOHNSON & JOHNSON
Report date April 23, 2026 · Filed April 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 7,730.0491 |
Reported balance
After 2026-04-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-23 · Grant · Acquired 975 · Balance 7,730.0491 F1: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
F2: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
NUCOR CORP
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,703 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 755 · Balance 10,703 F1: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant.
TENET HEALTHCARE CORP
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,653 |
Reported balance
After 2026-09-02 transaction · row 1
1 source rowRow 1 · 2026-09-02 · Sale · Disposed 1,152 · Balance 23,653 |
Tempus AI, Inc.
Report date August 28, 2026 · Filed September 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 31,981 |
Reported balance
After 2026-08-28 transaction · row 1
1 source rowRow 1 · 2026-08-28 · Sale · Disposed 3,000 · Balance 31,981 F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 4, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 1,152 | $258.80 | $298,137.60 |
DisclosureSEC source: 0001193125-26-382368 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,653 Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 20:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 3,000 | $69.00 | $207,000.00 |
DisclosureSEC source: 0001787802-26-000006 · form4-09012026_040903.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,981 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2026. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 3,000 | $53.90 | $161,700.00 |
DisclosureSEC source: 0001787802-26-000004 · form4-08182026_040807.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,981 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2026. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 18:45 UTC | NUCOR CORP NUE · Entity 3010 | GrantCommon Stock | 755 | $0.00 | $0.00 |
DisclosureSEC source: 0000073309-26-000119 · form4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,703 F1 · shares: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245811 · ownership.xml · derivative · entry 2 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 3,000 | $177.35 | $532,050.00 |
DisclosureSEC source: 0001193125-26-245811 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,805 Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239941 · ownership.xml · derivative · entry 3 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Disposition to issuerCommon Stock | 493 | $173.78 | $85,673.54 |
DisclosureSEC source: 0001193125-26-239941 · ownership.xml · nonDerivative · entry 2 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,805 Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239941 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 21, 2026 Filed May 27, 2026 01:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 5,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001787802-26-000002 · form4-05262026_090513.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,981 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on May 21, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 975 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000111 · wk-form4_1777328506.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,730.0491 Underlying: Common Stock · 975 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GiftCommon Stock | 1,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057752 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,965 F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 2,178 | $197.47 | $430,089.66 |
DisclosureSEC source: 0001193125-25-323306 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,480 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $197.47 to $197.57. F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 16:27 UTC | NUCOR CORP NUE · Entity 3010 | GrantCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016335 · form4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,948 F1 · shares: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionRestricted Stock Units · Derivative | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078024 · ownership.xml · derivative · entry 4 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of her restricted stock units for cash and 63% for shares of THC common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of her restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Disposition to issuerCommon Stock | 573 | $161.33 | $92,442.09 |
DisclosureSEC source: 0000950170-25-078024 · ownership.xml · nonDerivative · entry 2 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,658 Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078024 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of her restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-078024 · ownership.xml · derivative · entry 3 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 F2 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 20, 2025 Filed May 23, 2025 00:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Comnmon Stock | 1,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014311 · form4-05222025_080528.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,068 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the Issuer's 2026 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on May 20, 2026, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 21:54 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000135 · wk-form4_1745877247.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,572.6091 Underlying: Common Stock · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 700 | $50.63 | $35,441.00 |
DisclosureSEC source: 0001415889-25-008655 · form4-03192025_060308.xml · nonDerivative · entry 5 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,071 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.72 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 2,789 | $50.05 | $139,589.45 |
DisclosureSEC source: 0001415889-25-008655 · form4-03192025_060308.xml · nonDerivative · entry 4 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,771 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.46 to $50.43 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 760 | $48.94 | $37,194.40 |
DisclosureSEC source: 0001415889-25-008655 · form4-03192025_060308.xml · nonDerivative · entry 3 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,560 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.45 to $49.43 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,900 | $48.13 | $91,447.00 |
DisclosureSEC source: 0001415889-25-008655 · form4-03192025_060308.xml · nonDerivative · entry 2 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,320 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.44 to $48.43 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,485 | $46.66 | $69,290.10 |
DisclosureSEC source: 0001415889-25-008655 · form4-03192025_060308.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,220 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.22 to $47.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6). Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 160 | $53.24 | $8,518.40 |
DisclosureSEC source: 0001415889-25-007242 · form4-03062025_050301.xml · nonDerivative · entry 5 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,705 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.10 to $53.46 inclusive. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 249 | $52.60 | $13,097.40 |
DisclosureSEC source: 0001415889-25-007242 · form4-03062025_050301.xml · nonDerivative · entry 4 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,865 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.95 to $52.91 inclusive. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 80 | $50.93 | $4,074.40 |
DisclosureSEC source: 0001415889-25-007242 · form4-03062025_050301.xml · nonDerivative · entry 3 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,114 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.52 to $51.33 inclusive. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 120 | $49.81 | $5,977.20 |
DisclosureSEC source: 0001415889-25-007242 · form4-03062025_050301.xml · nonDerivative · entry 2 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,194 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.45 to $50.38 inclusive. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 200 | $48.40 | $9,680.00 |
DisclosureSEC source: 0001415889-25-007242 · form4-03062025_050301.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,314 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.97 to $48.92 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6). Read SEC document |
| June 13, 2024 Filed Jun 18, 2024 01:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 38,514 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-017304 · form4-06172024_090608.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,514 F1 · shares: Consists of previously granted restricted stock units ("RSUs") for which the liquidity event-based condition was satisfied upon the effectiveness of the registration statement on Form S-1 filed by the Issuer in connection with the Issuer's initial public offering, as well as, a grant of RSUs made in connection with the Issuer's Non-Employee Director Compensation Policy. Certain of the RSUs remain subject to service-based vesting conditions, as follows: (i) 8,750 RSUs vest in seven equal quarterly installments commencing on July 1, 2024 and (ii) 13,514 RSUs vest in 20 substantially equal quarterly installments commencing on September 13, 2024. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 15:43 UTC | NUCOR CORP NUE · Entity 3010 | GrantCommon Stock | 1,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017542 · form4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,394 F1 · shares: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. Read SEC document |
| May 23, 2024 Filed May 29, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065546 · ownership.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,551 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 09, 2024 Filed May 11, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 1,782 | $126.41 | $225,262.62 |
DisclosureSEC source: 0000950170-24-058086 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,680 Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:06 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,385.697 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005334 · doc4.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,093.682 Underlying: Common Stock · 1,385.697 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 19:32 UTC | NUCOR CORP NUE · Entity 3010 | GrantCommon Stock | 1,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017772 · form4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,388 F1 · shares: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. Read SEC document |
| May 26, 2023 Filed May 30, 2023 21:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 2,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032960 · doc4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,626 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| May 26, 2023 Filed Jun 23, 2023 23:49 UTC Amendment | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039560 · doc4a.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,462 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F2 · shares: This amendment is being filed to correct the amount of restricted stock units granted on May 26, 2023. Read SEC document |
| April 27, 2023 Filed May 2, 2023 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,193.975 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005257 · doc4.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,598.846 Underlying: Common Stock · 1,193.975 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 14:51 UTC | NUCOR CORP NUE · Entity 3010 | GrantCommon Stock | 1,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016561 · form4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,148 F1 · shares: The shares of common stock reported are issuable to the reporting person, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:11 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028352 · doc4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,780 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002583 · doc4.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,326.845 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 15:36 UTC | NUCOR CORP NUE · Entity 3010 | GrantCommon Stock | 1,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018863 · form4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,886 F1 · shares: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. Read SEC document |
| May 07, 2021 Filed May 11, 2021 22:07 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031826 · doc4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,944 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002227 · doc4.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123 Underlying: Common Stock · 1,123 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 13:51 UTC | NUCOR CORP NUE · Entity 3010 | GrantCommon Stock | 3,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018574 · form4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,532 F1 · shares: The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 23:25 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 11,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033760 · doc4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,984 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 13:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | PurchaseCommon Stock | 1,000 | $15.42 | $15,420.00 |
DisclosureSEC source: 0001209191-20-019444 · doc4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,845 F1 · shares: The shares were purchased in open market broker transactions. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:10 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 7,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055025 · doc4.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,845 F1 · security: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 2,566 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 5,279 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 2,566 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 5,279 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.